Background Image
Table of Contents Table of Contents
Previous Page  186 / 294 Next Page
Information
Show Menu
Previous Page 186 / 294 Next Page
Page Background

186

Biophysical Society 59

th

Annual Meeting, Baltimore, Maryland

10:30

am

–12:00

noon

Molecular Devices LLC

Performing Positive Allosteric Modulator (PAM) Assays and

Investigating Use-Dependent Inhibition of Ion Channels on

Automated Electrophysiology Systems Including the IonFlux

tm

Benchtop Reader and the IonWorks Barracuda® Instrument

PAM Assays

Nicotinic acetylcholine receptors (nAChRs) have been extensively studied

due to their importance in physiological processes as well as involvement in

several muscle and neuronal human pathologies, and are major therapeutic

targets for pharmaceutical drug discovery. Ensemble recordings on the

IonFlux HT System were validated with human hnAChR recombinant cell

lines developed by Eurofins Discovery Services. Response properties of the

nAChRs to the endogenous ligand acetylcholine (ACh), reference agonists,

antagonists and positive allosteric modulators (PAMs) were characterized

and will be presented.

Ion Channel Use-Dependence

Use-dependent inhibition of ion channels by potential drug candidates is

an important aspect to investigate for many drug classes. Data will be pre-

sented to demonstrate the ability of automated electrophysiology systems to

study the use-dependence block of Na+ channel targets by peptide toxins

and known compounds. We will demonstrate the ability of the IonWorks

Barracuda system to deliver complex voltage protocols and generate long

assay windows which are required for these studies.Pulse trains delivered

at 10Hz are used to measure the blockade of current. These experiments

demonstrate stable assay windows with uniform currents for 30 minutes and

longer during the delivery of periodic pulse trains.

Presenter

James Costantin, Product Marketing Manager, Automated

Electrophysiology, Molecular Devices LLC

12:30

pm

–2:00

pm

Nanion Technologies GmbH

HTS-Compatible Giga-Seal Ion Channel Drug Discovery: Beyond the

Bottleneck and Ready for CiPA

Nanion Technologies is one of the leading providers of automated patch

clamp systems, offering a diverse product portfolio covering a broad

experimental range from single channel recordings to HTS-compatible

ion channel screening from up to 768 cells in parallel. Allowing 20,000

data points per day, the SyncroPatch 384/768PE is unrivalled for high

throughput and high quality recordings. Diverse ion channel targets and

cell types have successfully been tested on the SyncroPatch 384/768PE

including challenging targets such as fast desensitizing ligand ion chan-

nels (P2X3 und GluA2), ion channels requiring intracellular activation

(Katp, TMEM16a) and heavily regulated channels such as TRPA1.

Early cardiac arrhythmic risk assessment is a hot topic these days calling

for new safety screening strategies. Patchliner, a medium-throughput APC

platform, supports automated current clamp recordings, experiments at

physiological temperatures, and a minimal cell usage, making it the ideal

partner for safety testing on stem cell derived cardiomyocytes. Additionally,

the CardioExcyte 96, a unique hybrid system for parallel impedance-based

and MEA-like recordings from intact cardiomyocyte networks, has proven

a versatile tool for safety and toxicity screening applications serving as an

excellent complement to APC. These three platforms enable you to keep up

with the requirements of the CiPA-initiative for early prediction of potential

cardiac arrhythmias.

During this workshop, we will show how to push the boundaries of ion

channel screening projects to achieve HTS-screening standards, and how to

get ready for comprehensive safety screening beyond hERG.

Spaces are limited so reserve yours by sending an email to

info@nanion.de

.

Presenters

Niels Fertig, CEO, Nanion Technologies GmbH

Andrea Brüggemann, CSO, Nanion Technologies GmbH

2:30

pm

–4:00

pm

Sutter Instrument

Scientists Empowering Scientists

For over 40 years, Sutter Instrument has designed and produced electro-

mechanical and optical instrumentation that helps scientists push the limits.

While Sutter has long been the market leader in products for micropipette

fabrication and micromanipulation, we have continued to expand our

Lambda imaging product line and XenoWorks microinjection systems. A

strong emphasis has always been placed on providing expert tech support to

help our customers achieve the best results in their research.

To further this goal, Sutter Instrument is starting a series of user meetings

with tutorial presentations. We will be providing step-by-step guidance to

the new experimenter as well as advanced tips and tricks for the experienced

user. To round it off, newly introduced products will be discussed on a

case-by-case basis.

Registration is available online through the Sutter Event Registration

Page

(http://sutter.eventbrite.com

), or by email to

info@sutter.com

. The

number of available spaces is limited, and registrations are accepted on a

first-come-first-served basis.

Who should attend?

• Electrophysiologists who use micropipettes and micromanipulators for

patch clamp, sharp electrode or extracellular recordings.

• Researchers who perform microinjections, including nuclear transfer,

sperm injection and application of substances into cell cultures or intact

organisms.

• Scientists who want to learn more about optimizing their results with

pipette pullers and micromanipulators

Presenters

Jan Dolzer, Tech Support and Product Development, Sutter Instrument:

Introductory Remarks

Adair Oesterle, Tech Support Micropipette Fabrication and Microinjection,

Sutter Instrument: Optimizing Settings on Your Sutter Micropipette Puller

Ali Mahloudji, Tech Support Micromanipulators and Lambda DG Series,

Sutter Instrument: Maximizing the Versatility of Your Dual-manipulator

Setup